UK Parliament / Open data

IVF

Written question asked by Lord Alton of Liverpool (Crossbench) on Monday, 9 March 2015, in the House of Lords. It was due for an answer on Monday, 9 March 2015. It was answered by Earl Howe (Conservative) on Monday, 9 March 2015 on behalf of the Department of Health.

Question

To ask Her Majesty’s Government, further to the remarks by Lord Wallace of Saltaire on 11 February (HL Deb, col 1243), what consideration both they and the Human Fertilisation and Embryology Authority have given to the patent applications by Scott Webster Ballinger, Danny R. Welch, Robert Allen Kesterson and Larry W. Johnson (US20090328241, US 13/360,344) and by Shoukhrat M. Mitalipov (US20120036591, US 13/265,326); and what is their estimation of the potential impact of such patent applications on the promotion of economic growth by licensing the first clinical applications in the United Kingdom of (1) pronuclear transfer, and (2) spindle-chromosomal complex transfer.

Answer

Neither the Government nor the Human Fertilisation and Embryology Authority has made any such assessment.

Type
Written question
Reference
HL5133
Session
2014-15
Deregulation Bill
Wednesday, 11 February 2015
Proceeding contributions
House of Lords
Back to top